The article discusses Cerence Inc. (NASDAQ:CRNC) as one of the worst 52-week low stocks to buy according to short sellers. Despite challenges, Cerence remains positioned for growth in the GenAI market. The Fed's interest rate cut and hedge fund interest also influence stock performance.